Table 1.
TTE Studies Presented From the Initial Diagnosis Through the Final Evaluation
| TTE | LVEF, % | LV EDD/ESD, mm | IVS, mm | PW, mm | LA Area, cm2 | E/A | E′, cm/s |
|---|---|---|---|---|---|---|---|
| Baseline September 2016 |
60 | 38/23 | 13 | 12 | 19 | ||
| 8 weeks postdetraining February 2017 |
65 | 9 | 10 | ||||
| Follow-up December 2017 |
60 | 11 | 10 | ||||
| Follow-up August 2019 |
65 | 40/25 | 12 | 12 | 17 | 1.7 | |
| Follow-up March 2020 |
65 | 43/29 | 12 | 11 | 12 | ||
| Follow-up October 2021 |
65 | 49/28 | 13 | 11 | 19 | ||
| 7 months postdetraining August 2022 |
65 | 42/23 | 12 | 11 | 16 | 1.7 | 16 |
E′ = tissue velocity; E/A = mitral annular velocities ratio; EDD = end-diastolic diameter; ESD = end-systolic diameter; IVS = interventricular septum; LA = left atrium; LV = left ventricular; LVEF = left ventricular ejection fraction; PW = posterior wall; TTE = transthoracic echocardiography.